---
schema_version: "secwatch.filing_event.v1"
accession: "0000947871-25-000317"
form_type: "8-K"
ticker: "DGX"
cik: "0001022079"
company_name: "QUEST DIAGNOSTICS INC"
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T11:33:11.260210+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Quest Diagnostics provides long-term outlook: 4-5% revenue CAGR; reaffirms FY2025 guidance but notes Q1 weather headwind

## Summary
- Long-term outlook: revenue CAGR 4-5%, adjusted EPS CAGR 7-9% beyond 2025.
- Reaffirms FY2025 guidance: revenue $10.70B-$10.85B, adjusted EPS $9.55-$9.80.
- Q1 2025 weather headwind of ~$25M revenue and ~$0.10 EPS expected.
- Strategic initiatives include Invigorate productivity (3% annual savings) and Project Nova IT modernization.
- Double-digit growth targeted in advanced diagnostics: oncology, cardiometabolic, brain health, others.

## SEC filing metadata
- accession: 0000947871-25-000317
- form_type: 8-K
- ticker: DGX
- cik: 0001022079
- company_name: QUEST DIAGNOSTICS INC
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022079/000094787125000317/0000947871-25-000317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022079/000094787125000317/ss4592500_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000947871-25-000317
- JSON: https://secwatch.observer/filing/0000947871-25-000317.json
- Plain text: https://secwatch.observer/filing/0000947871-25-000317.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.